CAVALLARO, Lucas Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 1.761
AS - Asia 1.471
EU - Europa 1.015
SA - Sud America 171
AF - Africa 86
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 1
Totale 4.511
Nazione #
US - Stati Uniti d'America 1.716
SG - Singapore 556
CN - Cina 424
VN - Vietnam 229
DE - Germania 213
SE - Svezia 197
IE - Irlanda 189
BR - Brasile 128
IT - Italia 99
FI - Finlandia 88
HK - Hong Kong 78
ZA - Sudafrica 52
FR - Francia 50
NL - Olanda 38
TR - Turchia 38
GB - Regno Unito 33
IN - India 31
CA - Canada 28
RU - Federazione Russa 23
CI - Costa d'Avorio 21
AR - Argentina 17
BD - Bangladesh 17
BE - Belgio 15
MX - Messico 14
IQ - Iraq 13
PL - Polonia 13
IR - Iran 12
ES - Italia 11
EC - Ecuador 10
PK - Pakistan 10
LT - Lituania 8
CZ - Repubblica Ceca 7
ID - Indonesia 7
TH - Thailandia 7
UZ - Uzbekistan 7
AT - Austria 6
EU - Europa 6
NP - Nepal 5
SA - Arabia Saudita 5
HU - Ungheria 4
JP - Giappone 4
PH - Filippine 4
PY - Paraguay 4
TW - Taiwan 4
AE - Emirati Arabi Uniti 3
CL - Cile 3
CO - Colombia 3
GR - Grecia 3
IL - Israele 3
KG - Kirghizistan 3
MA - Marocco 3
RO - Romania 3
AZ - Azerbaigian 2
HR - Croazia 2
KE - Kenya 2
KR - Corea 2
LV - Lettonia 2
PE - Perù 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
AO - Angola 1
AU - Australia 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
CG - Congo 1
CH - Svizzera 1
CR - Costa Rica 1
CY - Cipro 1
DZ - Algeria 1
EG - Egitto 1
ET - Etiopia 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MD - Moldavia 1
MM - Myanmar 1
MU - Mauritius 1
MY - Malesia 1
NO - Norvegia 1
PA - Panama 1
QA - Qatar 1
RS - Serbia 1
SC - Seychelles 1
SR - Suriname 1
TN - Tunisia 1
UA - Ucraina 1
UY - Uruguay 1
VE - Venezuela 1
Totale 4.511
Città #
Ashburn 316
Chandler 307
Singapore 301
Dublin 176
Munich 164
Santa Clara 141
San Jose 103
Beijing 82
Hong Kong 77
Ho Chi Minh City 74
Helsinki 65
Boardman 63
Nanjing 60
Dearborn 55
Shanghai 53
Los Angeles 49
Johannesburg 48
Hanoi 47
Dallas 45
New York 43
Princeton 30
Izmir 28
Lauterbourg 27
Frankfurt am Main 25
Ann Arbor 23
Buffalo 22
Parma 22
Abidjan 21
Turku 21
Wilmington 17
Moscow 15
Pune 15
Brussels 14
Hefei 14
San Mateo 14
São Paulo 14
Nanchang 13
Shenyang 13
Tianjin 13
London 12
Toronto 12
Changsha 11
Boston 9
Can Tho 9
Haiphong 9
Kunming 9
Orem 9
Warsaw 9
Jiaxing 8
Jinan 8
Milan 8
Columbus 7
Da Nang 7
Hải Dương 7
Montreal 7
Norwalk 7
Bremen 6
Denver 6
Hangzhou 6
Houston 6
Kocaeli 6
Lahore 6
Phoenix 6
Chengdu 5
Chennai 5
Curitiba 5
Guangzhou 5
Hebei 5
Menlo Park 5
Quito 5
Seattle 5
Tashkent 5
Thái Bình 5
Zanjan 5
Baghdad 4
Bangkok 4
Brooklyn 4
Cambridge 4
Mexico City 4
Ningbo 4
Nuremberg 4
Olomouc 4
Thái Nguyên 4
Tokyo 4
Andover 3
Atlanta 3
Augusta 3
Bishkek 3
Biên Hòa 3
Brno 3
Bình Phước 3
Chicago 3
Erbil 3
Frattamaggiore 3
Grafing 3
Kathmandu 3
Long Xuyen 3
Marseille 3
Mumbai 3
Ottawa 3
Totale 2.963
Nome #
CS1.1 EFFICACY OF MESALAMINE AND THE ASSOCIATION OF MESALAMINE AND PROBIOTICS VERSUS RIFAXIMIN IN THE TREATMENT OF SYMPTOMATIC DIVERTICULAR DISEASE 278
Changes in surgical behaviors during the CoviD-19 pandemic. The SICE CLOUD19 Study 229
Correction to: Changes in surgicaL behaviOrs dUring the CoviD-19 pandemic. The SICE CLOUD19 Study (Updates in Surgery, (2021), 73, 2, (731-744), 10.1007/s13304-021-01010-w) 181
W1079 Curcumin Vs Domperidon in Functional Dyspepsia: Better the Prokinetic or An Agonist of Vanilloid Receptor? 165
710 Gastrin-17 (G-17): A Serological Bio-Marker for Diagnosis of Gastro-Esophageal Reflux Disease (GERD) 162
Quality of life in uncomplicated diverticular disease: Is it another good reason for the treatment? 154
Gastro panel® for detection of atrophic gastritis: The “Parma model” 146
S1921 “GastroPanel Test” in the Clinical Outcome of GERD 145
Serum pepsinogen II for early assessment of success of H. pylori eradication 144
Does chronic hypercalcemia influence serum pepsinogens levels? 142
Gastrin-17 (G-17) as a sensitive serological bio-marker for diagnosis of gastro-esophageal reflux disease (GERD) independently of H. pylori status 141
T1979 Pepsinogen II As Marker of Inflammation in H.P Infection and in NSAIDs Damage 140
OC1.09.3 USEFULNESS OF GASTROPANEL FOR SCREENING OF ATROPHIC GASTRITIS IN PATIENTS WITH AUTOIMMUNE THYROID DISEASES 136
INFLUENCE OF BMI ON GASTRIC ACID SECRETION IN ACID RELATED DISEASE 136
T1651 The Natural History of Gastric Ulcer: A Twenty-Four Years Clinical-Endoscopical Follow-Up 135
PA.28 SERUM PEPSINOGEN I AS NON INVASIVE MARKER OF GASTRIC ACID SECRETION 135
PA.7 CLINICAL VARIABILITY IN THE PRESENTATION OF THE GASTROESOPHAGEAL REFLUX DISEASE BEFORE THE HP ERA (STUDY FROM 1975 TO 1995) 133
Esophagitis: acute therapy with omeprazole (Single Dosage Versus BID) 133
OC3.07.1 CURCUMIN VS DOMPERIDON IN FUNCTIONAL DYSPEPSIA: BETTER THE PROKINETIC OR AN AGONIST OF VANILLOID RECEPTOR? 132
PA.27 GASTRO PANEL® FOR DETECTION OF ATROPHIC GASTRITIS: THE “PARMA MODEL” 131
NOD2 and Crohn’s Disease Clinical Practice: From Epidemiology to Diagnosis and Therapy, Rewired 130
PA.6 GASTRIN-17 (G-17): A SEROLOGICAL BIO-MARKER FOR DIAGNOSIS OF GASTRO-ESOPHAGEAL REFLUX DISEASE (GERD) 130
Gastroesophageal reflux disease in celiac patients: Preliminary results in 35 consecutive patients 127
Clinical presentation of 324 patients with hepatocellular carcinoma (HCC) in a single center of North Italy 126
The THYCOVIT (Thyroid Surgery during COVID-19 pandemic in Italy) study: results from a nationwide, multicentric, case-controlled study 126
A new curcumin-based one week therapy for eradication of H. pylori infection 120
“GASTROPANEL TEST” IN THE CLINICAL OUTCOME OF GERD 117
Cancro gastrico e Helicobacter pylori 114
Serum pepsinogen II and gastrin-17 as markers of NSAIDs gastropathy 114
PO.1 NERD AND ERD: THE SCENARIO IS CHANGING OVER THE TIME? A 30 YEARS FOLLOW UP STUDY 112
Impact of the COVID-19 pandemic on surgery for thyroid cancer in Italy: nationwide retrospective study 108
La diagnosi sierologica delle gastriti croniche atrofiche 105
null 30
Totale 4.557
Categoria #
all - tutte 15.198
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.198


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202142 0 0 0 0 0 0 0 0 0 30 8 4
2021/2022244 7 11 1 44 29 6 12 11 10 15 32 66
2022/2023808 67 99 71 86 56 100 5 64 223 4 31 2
2023/2024279 11 19 5 6 21 68 23 32 10 17 36 31
2024/20251.087 37 39 43 58 126 132 59 63 179 70 92 189
2025/20261.712 231 119 154 209 279 130 149 56 236 149 0 0
Totale 4.557